Literature DB >> 36028734

Naringenin Attenuates Cognitive Impairment in a Rat Model of Vascular Dementia by Inhibiting Hippocampal Oxidative Stress and Inflammatory Response and Promoting N-Methyl-D-Aspartate Receptor Signaling Pathway.

Jin Zhang1, Yu Zhang2, Yan Liu1, Xiaoyuan Niu3.   

Abstract

Vascular dementia (VaD) is the second most common form of dementia globally, yet there are no efficient treatments. Naringenin, a natural flavonoid, exerts antioxidative, anti-inflammatory, and neuroprotective properties; however, its potential effect on VaD remain unclear. Herein, the purpose of present study was to elucidate whether naringenin attenuates cognitive dysfunction in VaD via inhibiting hippocampal oxidative stress and inflammatory response, and promoting N-methyl-D-aspartate receptors (NMDARs) signaling pathway. A rat model of VaD was established by permanent bilateral common carotid artery occlusion [2-vessel occlusion (2VO)]. Behavioral performance analyses results revealed that administration of naringenin improves cognitive impairment in rats with VaD according to the new object recognition test and the Morris water maze test. In addition, naringenin attenuated hippocampal oxidative stress by reducing reactive oxygen species generation, decreasing malondialdehyde content and recombinant reactive oxygen species modulator 1 (Romo-1) expression, and increasing superoxide dismutase and glutathione peroxidase activities in the hippocampus of VaD rats. Moreover, naringenin decreased the proinflammatory cytokines (IL-1β, IL-6, and TNF-α) levels and increased the anti-inflammatory cytokines (IL-10 and IL-4) levels in the hippocampus of 2VO surgery-treated rats, attenuating hippocampal inflammatory response during VaD. Furthermore, naringenin promoted synaptophysin (SYP), postsynaptic density protein 95 (PSD95), N-methyl-Daspartic acid receptor 1 (NR1) and N-methyl-D-aspartate receptor subunit 2B (NR2B) expressions levels in hippocampus of VaD rats. Collectively, these findings indicated that naringenin mitigates cognitive impairment in VaD rats partly via inhibiting hippocampal oxidative stress and inflammatory response and restoring NMDARs signaling pathway.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cognitive impairment; Inflammatory response; N-methyl-D-aspartate receptor signaling pathway; Naringenin; Oxidative stress; Vascular dementia

Mesh:

Substances:

Year:  2022        PMID: 36028734     DOI: 10.1007/s11064-022-03696-9

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   4.414


  48 in total

1.  Developmental and regional expression in the rat brain and functional properties of four NMDA receptors.

Authors:  H Monyer; N Burnashev; D J Laurie; B Sakmann; P H Seeburg
Journal:  Neuron       Date:  1994-03       Impact factor: 17.173

Review 2.  NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease.

Authors:  Pierre Paoletti; Camilla Bellone; Qiang Zhou
Journal:  Nat Rev Neurosci       Date:  2013-06       Impact factor: 34.870

Review 3.  Cerebral hypoperfusion and cognitive impairment: the pathogenic role of vascular oxidative stress.

Authors:  Hui Liu; Junjian Zhang
Journal:  Int J Neurosci       Date:  2012-05-24       Impact factor: 2.292

Review 4.  Vascular dementia.

Authors:  John T O'Brien; Alan Thomas
Journal:  Lancet       Date:  2015-10-24       Impact factor: 79.321

Review 5.  The pathobiology of vascular dementia.

Authors:  Costantino Iadecola
Journal:  Neuron       Date:  2013-11-20       Impact factor: 17.173

Review 6.  Inflammation, apoptosis and autophagy as critical players in vascular dementia.

Authors:  X-X Wang; B Zhang; R Xia; Q-Y Jia
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-09       Impact factor: 3.507

Review 7.  Potential Therapeutics for Vascular Cognitive Impairment and Dementia.

Authors:  Miao-Kun Sun
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

Review 8.  Pharmacological Treatment of Vascular Dementia: A Molecular Mechanism Perspective.

Authors:  Huang Kuang; Zhi-Feng Zhou; Yu-Ge Zhu; Zhi-Kai Wan; Mei-Wen Yang; Fen-Fang Hong; Shu-Long Yang
Journal:  Aging Dis       Date:  2021-02-01       Impact factor: 6.745

Review 9.  The pathology and pathophysiology of vascular dementia.

Authors:  Raj N Kalaria
Journal:  Neuropharmacology       Date:  2017-12-19       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.